Home › Valeant Pharmaceuticals Intl's (VRX) Hold Rating Reiterated at Morgan Stanley
 

Keywords :   


Valeant Pharmaceuticals Intl's (VRX) Hold Rating Reiterated at Morgan Stanley

2015-12-16 07:40:59| Biotech - Topix.net

's stock had its "hold" rating reiterated by equities researchers at Morgan Stanley in a research note issued to investors on Tuesday, MarketBeat reports. Shares of Valeant Pharmaceuticals Intl traded up 16.41% during midday trading on Tuesday, reaching $109.59.

Tags: rating hold morgan stanley

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
More »